DOCSLIB.ORG

Definitions of Medicare Code Edits

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Definitions of Medicare Code Edits Preliminary 08/25/09 Definitions of Medicare Code Edits PBL–011 October 2009 08/25/09 Preliminary Document number PBL–011 October 2009 ii Definitions of Medicare Code Edits October 2009 Preliminary 08/25/09 About this document THE MEDICARE CODE EDITOR (MCE) detects and reports errors in the coding claims data. This manual contains a description of each coding edit with corresponding ICD-9-CM code lists. The coding edit information in this manual is effective from 10/01/2009 to 09/30/2010. October 2009 iii 08/25/09 Preliminary iv Definitions of Medicare Code Edits October 2009 Preliminary 08/25/09 Contents Preface About this document iii Chapter 1 Edit code lists 1.3 1. Invalid diagnosis or procedure code 1.4 2. E-code as principal diagnosis 1.4 3. Duplicate of PDX 1.4 4. Age conflict 1.4 5. Sex conflict 1.19 6. Manifestation code as principal diagnosis 1.38 7. Non-specific principal diagnosis 1.41 8. Questionable admission 1.41 9. Unacceptable principal diagnosis 1.42 10. Non-specific O.R. procedure 1.50 11. Non-covered procedure 1.50 12. Open biopsy check 1.53 13. Bilateral procedure 1.54 14. Invalid age 1.55 15. Invalid sex 1.55 16. Invalid discharge status 1.55 17. Limited coverage 1.56 18. Wrong procedure performed 1.57 Chapter 2 Code list changes 2.3 Changes to existing edits 2.3 New edit 2.13 Index I.1 October 2009 Contents v 08/25/09 Preliminary vi Definitions of Medicare Code Edits October 2009 Chapter 1 1Edit code lists Contents Edit code lists 1.3 1. Invalid diagnosis or procedure code 1.4 2. E-code as principal diagnosis 1.4 3. Duplicate of PDX 1.4 4. Age conflict 1.4 5. Sex conflict 1.19 6. Manifestation code as principal diagnosis 1.38 7. Non-specific principal diagnosis 1.41 8. Questionable admission 1.41 9. Unacceptable principal diagnosis 1.42 10. Non-specific O.R. procedure 1.50 11. Non-covered procedure 1.50 12. Open biopsy check 1.53 13. Bilateral procedure 1.54 14. Invalid age 1.55 15. Invalid sex 1.55 16. Invalid discharge status 1.55 17. Limited coverage 1.56 18. Wrong procedure performed 1.57 1.2 Definitions of Medicare Code Edits October 2009 Chapter 1 Edit code lists BELOW IS A LIST of current edits described in this chapter. 1. Invalid diagnosis or procedure code 2. E-code as principal diagnosis 3. Duplicate of PDX 4. Age conflict 5. Sex conflict 6. Manifestation code as principal diagnosis 7. Non-specific principal diagnosis (Discontinued as of 10/01/07) 8. Questionable admission 9. Unacceptable principal diagnosis 10. Non-specific O.R. procedure (Discontinued as of 10/01/07) 11. Non-covered procedure 12. Open biopsy check 13. Bilateral procedure 14. Invalid age 15. Invalid sex 16. Invalid discharge status 17. Limited coverage 18. Wrong procedure performed October 2009 Edit code lists 1.3 1. Invalid1. diagnosis Invalid or diagnosis procedure code or The Medicare Code Editor checks each diagnosis including the admit- procedure code ting diagnosis and each procedure against a table of valid ICD-9-CM codes. If an entered code does not agree with any code on the internal list, it is assumed to be invalid or that the 4th or 5th digit of the code is invalid or missing. 2. 2.E-code E-code as principal as principal diagnosis For a list of all valid ICD-9-CM codes, see volumes 2 (diseases) and 3 diagnosis (procedures) of the International Classification of Diseases, 9th Revi- sion, Fourth Edition, Clinical Modification (ICD-9-CM). E-codes are ICD-9-CM codes beginning with the letter E. They describe the circumstance causing an injury, not the nature of the injury, and therefore should not be used as a principal diagnosis. For a list of all E-codes, see volume 2 (diseases) of the International Classification of Diseases, 9th Revision, Fourth Edition, Clinical Modification (ICD-9-CM). 3. Duplicate of PDX Whenever a secondary diagnosis is coded the same as the principal diagnosis, the secondary diagnosis is identified as a duplicate of the principal diagnosis. 4. Age conflict The Medicare Code Editor detects inconsistencies between a patient’s age and any diagnosis on the patient’s record. For example, a five-year-old patient with benign prostatic hypertrophy or a 78-year-old patient coded with a delivery. In the above cases, the diagnosis is clinically and virtually impossible in a patient of the stated age. Therefore, either the diagnosis or the age is presumed to be incorrect. There are four age categories for diag- noses in the program: ◆ Newborn. Age of 0 years; a subset of diagnoses intended only for newborns and neonates (e.g., fetal distress, perinatal jaundice). ◆ Pediatric. Age range is 0–17 years inclusive (e.g., Reye’s syn- drome, routine child health exam). ◆ Maternity. Age range is 12–55 years inclusive (e.g., diabetes in pregnancy, antepartum pulmonary complication). ◆ Adult. Age range is 15–124 years inclusive (e.g., senile delirium, mature cataract). The following pages contain lists of ICD-9-CM diagnosis codes with corresponding English descriptions for each of the age categories described above. 1.4 Definitions of Medicare Code Edits October 2009 Newborn diagnoses 27701 Cystic fibrosis w ileus 76497 Fet grwth ret 1750-1999g 74783 Persistent fetal circ 76498 Fet grwth ret 2000-2499g 76077 Mat anticonv aff NB/fet 76499 Fet growth ret 2500+g 76078 Mat antimetabol aff NB 76500 Extreme immatur wtNOS 7620 Placenta previa aff NB 76501 Extreme immatur <500g 7621 Placenta hem NEC aff NB 76502 Extreme immatur 500-749g 7622 Abn plac NEC/NOS aff NB 76503 Extreme immatur 750-999g 7623 Placent transfusion syn 76504 Extreme immat 1000-1249g 7624 Prolapsed cord aff NB 76505 Extreme immat 1250-1499g 7625 Oth umbil cord compress 76506 Extreme immat 1500-1749g 7626 Umbil cond NEC aff NB 76507 Extreme immat 1750-1999g 7627 Chorioamnionitis aff NB 76508 Extreme immat 2000-2499g 7628 Abn amnion NEC aff NB 76509 Extreme immat 2500+g 7629 Abn amnion NOS aff NB 76510 Preterm infant NEC wtNOS 7630 Breech del/extrac aff NB 76511 Preterm NEC <500g 7631 Malpos/dispro NEC aff NB 76512 Preterm NEC 500-749g 7632 Forceps delivery aff NB 76513 Preterm NEC 750-999g 7633 Vacuum extrac del aff NB 76514 Preterm NEC 1000-1249g 7634 Cesarean delivery aff NB 76515 Preterm NEC 1250-1499g 7635 Mat anesth/analg aff NB 76516 Preterm NEC 1500-1749g 7636 Precipitate del aff NB 76517 Preterm NEC 1750-1999g 7637 Abn uterine contr aff NB 76518 Preterm NEC 2000-2499g 76381 Ab ftl hrt rt/rh b/f lab 76519 Preterm NEC 2500+g 76382 Ab ftl hrt rt/rh dur lab 76520 Weeks of gestation NOS 76383 Ab ftl hrt rt/rhy NOS 76521 <24 comp wks gestation 76384 Meconium dur del aff NB 76522 24 comp weeks gestation 76389 Compl del NEC aff NB 76523 25-26 comp wks gestation 7639 Compl deliv NOS aff NB 76524 27-28 comp wks gestation 76400 Light-for-dates wtNOS 76525 29-30 comp wks gestation 76401 Light-for-dates <500g 76526 31-32 comp wks gestation 76402 Lt-for-dates 500-749g 76527 33-34 comp wks gestation 76403 Lt-for-dates 750-999g 76528 35-36 comp wks gestation 76404 Lt-for-dates 1000-1249g 76529 37+ comp wks gestation 76405 Lt-for-dates 1250-1499g 7660 Exceptionally large baby 76406 Lt-for-dates 1500-1749g 7661 Heavy-for-date infan NEC 76407 Lt-for-dates 1750-1999g 76621 Post-term infant 76408 Lt-for-dates 2000-2499g 76622 Prolong gestation-infant 76409 Lt-for-dates 2500+g 7670 Cerebral hem at birth 76410 Lt-for-date w/mal wtNOS 76711 Epicranial subapo hemorr 76411 Lt-for-date w/mal <500g 76719 Injuries to scalp NEC 76412 Lt-date w/mal 500-749g 7672 Clavicle fx at birth 76413 Lt-date w/mal 750-999g 7673 Bone injury NEC at birth 76414 Lt-date w/mal 1000-1249g 7674 Spinal cord inj at birth 76415 Lt-date w/mal 1250-1499g 7675 Facial nerve inj-birth 76416 Lt-date w/mal 1500-1749g 7676 Brach plexus inj-birth 76417 Lt-date w/mal 1750-1999g 7677 Nerve inj NEC at birth 76418 Lt-date w/mal 2000-2499g 7678 Birth trauma NEC 76419 Lt-for-date w/mal 2500+g 7679 Birth trauma NOS 76420 Fetal malnutrition wtNOS 7680 Fetal death-anoxia NOS 76421 Fetal malnutrition <500g 7681 Fet death-anoxia dur lab 76422 Fetal malnutr 500-749g 7682 Fet distress befor labor 76423 Fetal mal 750-999g 7683 Fetal distrs dur lab/del 76424 Fetal mal 1000-1249g 7684 Fetal distress NOS 76425 Fetal mal 1250-1499g 7685 Severe birth asphyxia 76426 Fetal mal 1500-1749g 7686 Mild/mod birth asphyxia 76427 Fetal malnutr 1750-1999g 76870 Hypoxc-ischem enceph NOS 76428 Fetal malnutr 2000-2499g 76871 Mild hypox-ischem enceph 76429 Fetal malnutr 2500+g 76872 Mod hypox-ischem enceph 76490 Fet growth retard wtNOS 76873 Sev hypox-ischem enceph 76491 Fet growth retard <500g 7689 Birth asphyxia NOS 76492 Fet growth ret 500-749g 769 Respiratory distress syn 76493 Fet growth ret 750-999g 7700 Congenital pneumonia 76494 Fet grwth ret 1000-1249g 77010 Fetal & newborn asp NOS 76495 Fet grwth ret 1250-1499g 77011 Meconium asp wo resp sym 76496 Fet grwth ret 1500-1749g 77012 Meconium asp w resp symp October 2009 Edit code lists 1.5 Newborn diagnoses 77013 Amniotc asp w/o resp sym 7756 Neonatal hypoglycemia 77014 Amniotic asp w resp sym 7757 Late metab acidosis NB 77015 Blood asp w/o resp sympt 77581 NB acidosis NEC 77016 Blood asp w resp sympt 77589 Neonat endo/met dis NEC 77017 NB asp w/o resp symp NEC 7759 Transient met dis NB NOS 77018 NB asp w resp symp NEC 7760 NB hemorrhagic disease 7702 NB interstit emphysema 7761 Neonatal thrombocytopen 7703 NB pulmonary hemorrhage 7762 Dissem intravasc coag NB 7704 Primary atelectasis 7763 Oth neonatal coag dis 7705 NB atelectasis NEC/NOS 7764 Polycythemia neonatorum 7706 NB transitory tachypnea 7765 Congenital anemia 77081 Primary apnea of newborn 7766 Anemia of prematurity
Load more

Recommended publications
  • Gyn Oncology Colposcopy I. Basic Science/Mechanisms of Disease A
    Gyn Oncology Colposcopy I. Basic Science/Mechanisms of Disease A. Genetics 1. Describe the clinical relevance of viral oncogenes. 2. Describe the role of aneuploidy in the pathogenesis of neoplasia. 3. Describe the inheritance patterns for malignancies of the pelvic organs and breast. 4. Describe the cell replication cycle, and identify the phases of the cycle most sensitive to radiation and chemotherapy. 5. Describe the genetic basis for tumor immunotherapy. B. Physiology 1. Describe the ability of vital organ systems to tolerate cancer therapy. 2. Describe the changes in cellular physiology that result from injury due to radiation and chemotherapy. 3. Describe the metabolic changes that occur in patients with a malignancy of the pelvic organs or breast. C. Embroyology 1. Describe the embryology of gonadal migration and its role in the pathogenesis of epithelial cell tumors. 2. Describe the pathogenesis of gonadal tumors in patients with gonadal dysgenesis. 3. Describe the embryologic precursors of ovarian germ cell tumors. D. Anatomy 1. Describe the gross histologic anatomy of the pelvic organs and breast. 2. Describe the vascular, lymphatic, and nerve supply to each of the pelvic organs. 3. Describe the anatomic relationship between the reproductive organs and other viscera, such as bladder, ureters, and bowel. 4. Describe the likely changes in the anatomic relationships of the pelvic and abdominal viscera created by surgical or radiation treatment for malignancy. E. Pharmacology 1. List major chemotherapeutic agents used for treatment of malignancies of the reproductive organs and breast. 2. Describe the principal adverse effects of the major chemotherapeutic agents. 3. Describe the medications of most value in treatment of complications resulting from chemotherapy and irradiation, such as: a.
    [Show full text]
  • Physiology of Female Sexual Function and Dysfunction
    International Journal of Impotence Research (2005) 17, S44–S51 & 2005 Nature Publishing Group All rights reserved 0955-9930/05 $30.00 www.nature.com/ijir Physiology of female sexual function and dysfunction JR Berman1* 1Director Female Urology and Female Sexual Medicine, Rodeo Drive Women’s Health Center, Beverly Hills, California, USA Female sexual dysfunction is age-related, progressive, and highly prevalent, affecting 30–50% of American women. While there are emotional and relational elements to female sexual function and response, female sexual dysfunction can occur secondary to medical problems and have an organic basis. This paper addresses anatomy and physiology of normal female sexual function as well as the pathophysiology of female sexual dysfunction. Although the female sexual response is inherently difficult to evaluate in the clinical setting, a variety of instruments have been developed for assessing subjective measures of sexual arousal and function. Objective measurements used in conjunction with the subjective assessment help diagnose potential physiologic/organic abnormal- ities. Therapeutic options for the treatment of female sexual dysfunction, including hormonal, and pharmacological, are also addressed. International Journal of Impotence Research (2005) 17, S44–S51. doi:10.1038/sj.ijir.3901428 Keywords: female sexual dysfunction; anatomy; physiology; pathophysiology; evaluation; treatment Incidence of female sexual dysfunction updated the definitions and classifications based upon current research and clinical practice.
    [Show full text]
  • ICD10 Diagnoses FY2018 AHD.Com
    ICD10 Diagnoses FY2018 AHD.com A020 Salmonella enteritis A5217 General paresis B372 Candidiasis of skin and nail A040 Enteropathogenic Escherichia coli A523 Neurosyphilis, unspecified B373 Candidiasis of vulva and vagina infection A528 Late syphilis, latent B3741 Candidal cystitis and urethritis A044 Other intestinal Escherichia coli A530 Latent syphilis, unspecified as early or B3749 Other urogenital candidiasis infections late B376 Candidal endocarditis A045 Campylobacter enteritis A539 Syphilis, unspecified B377 Candidal sepsis A046 Enteritis due to Yersinia enterocolitica A599 Trichomoniasis, unspecified B3781 Candidal esophagitis A047 Enterocolitis due to Clostridium difficile A6000 Herpesviral infection of urogenital B3789 Other sites of candidiasis A048 Other specified bacterial intestinal system, unspecified B379 Candidiasis, unspecified infections A6002 Herpesviral infection of other male B380 Acute pulmonary coccidioidomycosis A049 Bacterial intestinal infection, genital organs B381 Chronic pulmonary coccidioidomycosis unspecified A630 Anogenital (venereal) warts B382 Pulmonary coccidioidomycosis, A059 Bacterial foodborne intoxication, A6920 Lyme disease, unspecified unspecified unspecified A7740 Ehrlichiosis, unspecified B387 Disseminated coccidioidomycosis A080 Rotaviral enteritis A7749 Other ehrlichiosis B389 Coccidioidomycosis, unspecified A0811 Acute gastroenteropathy due to A879 Viral meningitis, unspecified B399 Histoplasmosis, unspecified Norwalk agent A938 Other specified arthropod-borne viral B440 Invasive pulmonary
    [Show full text]
  • Womens Health Requisition Forms
    PCR - WHI Implementation PLACE ON SWAB 10854 Midwest Industrial Blvd. St. Louis, MO 63132 MM DD YY Phone: (314) 200-3040 | Fax (314) 200-3042 (1) CLIA ID #26D0953866 JANE DOE v3 PCR MOLECULAR REQUISITION - WOMEN'S HEALTH INFECTION PRACTICE INFORMATION PATIENT INFORMATION *SPECIMEN INFORMATION (2) DOE JANE MM/DD/YY LAST NAME FIRST NAME DATE COLLECTED W O M E ' N S H E A L T H I F N E C T I O N SSN MM/DD/YY HH:MM AM SSN DATE OF BIRTH TIME COLLECTED REQUESTING PHYSICIAN: DR. SWAB TESTER (3) Sex: F X M (4) Diagnosis Codes X N76.0 Acute vaginitis B37.49 Other urogenital candidiasis A54.9 Gonococcal infection, unspecified N76.1 Subacute and chronic vaginitis N89.8 Other specified noninflammatory disorders of vagina A59.00 Urogenital trichomoniasis, unspecified N76.2 Acute vulvitis O99.820 Streptococcus B carrier state complicating pregnancy A64 Unspecified sexually transmitted disease N76.3 Subacute and chronic vulvitis O99.824 Streptococcus B carrier state complicating childbirth A74.9 Chlamydial infection, unspecified N76.4 Abscess of vulva B95.1 Streptococcus, group B, as the cause Z11.3 Screening for infections with a predmoninantly N76.5 Ulceration of vagina of diseases classified elsewhere sexual mode of trasmission N76.6 Ulceration of vulva Z22.330 Carrier of group B streptococcus Other: N76.81 Mucositis(ulcerative) of vagina and vulva N70.91 Salpingitis, unspecified N76.89 Other specified inflammation of vagina and vulva N70.92 Oophoritis, unspecified N95.2 Post menopausal atrophic vaginitis N71.9 Inflammatory disease of uterus, unspecified
    [Show full text]
  • AAGL Practice Report: Practice Guidelines for Management of Intrauterine Synechiae
    Special Article AAGL Practice Report: Practice Guidelines for Management of Intrauterine Synechiae AAGL ADVANCING MINIMALLY INVASIVE GYNECOLOGY WORLDWIDE Background The search was not restricted to English language literature; committee members fluent in languages other than English re- Intrauterine adhesions (IUAs) have been recognized as viewed relevant articles and provided the committee with rel- a cause of secondary amenorrhea since the end of the 19th ative information translated into English. Because of the century [1], and in the mid-20th century, Asherman further paucity of data in this area, all published works were included described the eponymous condition occurring after preg- for the electronic database searches, and relevant articles not nancy [2]. The terms ‘‘Asherman syndrome’’ and IUAs are available in electronic sources (e.g., published before the be- often used interchangeably, although the syndrome requires ginning of electronic database commencement) were cross- the constellation of signs and symptoms (in this case, pain, referenced from hand-searched bibliographies and included menstrual disturbance, and subfertility in any combination) in the literature review. When necessary, authors were con- and the presence of IUAs [2]. The presence of IUAs in the tacted directly for clarification of points published. absence of symptoms may be best referred to as asymptom- atic IUAs or synechiae. Diagnosis Identification and Assessment of Evidence In women with suspected IUAs, physical examination usually fails to reveal abnormalities [3,4]. Blind transcervical This AAGL Practice Guideline was produced after elec- sounding of the uterus may reveal cervical obstruction at or tronic resources including Medline, PubMed, CINAHL, the near the level of the internal os [3].
    [Show full text]
  • OBGYN Student Guide 2014.Pdf
    TABLE OF CONTENTS COMMON ABBREVIATIONS • 3 COMMON PRESCRIPTIONS • 4 OBSTETRICS • 5 What is a normal morning like on OB? • 5 What are good questions to ask a post-op/post-partum patient in the morning? • 6 How do I manage a post-partum patient? • 7 How should I organize and write my post-partum note? • 8 How do I present a patient on rounds? • 9 How do I evaluate a patient in triage/L&D? • 9 What are the most common complaints presented at triage/L&D? • 10 How should I organize and write my note for a triage H&P? • 12 What are the most common reasons people are admitted? • 13 How do I deliver a baby? • 13 What is my role as a student in a Cesarean section or tubal ligation procedure? • 15 How do I write up post-op orders? • 15 GYNECOLOGY/GYNECOLOGY ONCOLOGY • 17 What should I do to prepare for a GYN surgery? • 17 How do I manage a Gynecology/Gynecology Oncology patient? • 17 How should I organize and write my post-op GYN note? • 18 How do I write admit orders? • 19 What do routine post-op orders (Day #1) look like? • 19 What are the most common causes of post-operative fever? • 20 CLINIC • 21 What is my role as a student in clinic? • 21 What should I include in my prenatal clinic note? • 21 What should I include in my GYN clinic note? • 22 COMMON PIMP QUESTIONS • 23 2 COMMON ABBREVIATIONS 1°LTCS- primary low transverse cesarean LOF- leakage of fluid section NST- nonstress test AFI- amniotic fluid index NSVD- normal spontaneous vaginal delivery AROM- artificial rupture of membranes NT/NE- non-tender/non-engorged (breast BPP- biophysical
    [Show full text]
  • Culdocentesis in Diagnosis of Disturbed Ectopic Pregnancy Still a Useful Procedure in Developing Countries
    CULDOCENTESIS IN DIAGNOSIS OF DISTURBED ECTOPIC PREGNANCY STILL A USEFUL PROCEDURE IN DEVELOPING COUNTRIES Pages with reference to book, From 5 To 6 Tasneem Aslam Tariq ( Department of Obstetrics and Gynaecology, Jinnah Postgraduate Medical Centre, Karachi. ) Razia Korejo ( Department of Obstetrics and Gynaecology, Jinnah Postgraduate Medical Centre, Karachi. ) ABSTRACT Over a period of 5 years culdocentesis was carried out in 156 cases of suspected ectopic pregnancy using needle aspiration through the pouch of Douglas. The result was positive in 134 cases, with 131 being true positive and 3 false positive. In 22 cases the result was negative, 6 of which were false negative. It is concluded that culdocentesis is an effective method of diagnosing disturbed ectopic pregnancy (JPMA 42: 5, 1992). INTRODUCTION Ectopic pregnancy, a clinical diagnosis in majority of cases is infrequently seen in our hospital. Since it can present with varied symptoms, diagnosis can be difficult in some cases. To increase the accuracy rate of preoperative diagnosis in suspected cases of ectopic pregnancy, various diagnostic procedures have been employed over the years. The purpose of this study was to evaluate the efficacy of culdocentesis for the diagnosis of ectopic pregnancy. PATIENTS AND METHOD The present study included 156 suspected cases of ectopic pregnancy admitted to the Department of Obstetrics and Gynaecology between January, 1985 to December 1989. Culdocentesis was done in the operating theatre under aseptic precautions with or without general anaesthesia depending on the certainty of the diagnosis. Urinary bladder was catheterized and gentle bimanual vaginal examination was done to confirm the previous vaginal findings. Sims speculum was introduced in the vagina and posterior lip of cervix was held gently with a Vulsellum forceps, pulled upwards and forwards exposing the posterior fornix.
    [Show full text]
  • Women's Health Course Guide
    Course Guide for Women’s Health 1 Approach to the Patient The OB/GYN History Rationale: A gynecological evaluation is an important part of primary health care and preventive medicine for women. A gynecological assessment should be a part of every woman’s general medical history and physical examination. Certain questions must be asked of every woman, whereas other questions are specific to particular problems. To accomplish these objectives, optimal communication must be achieved between patient and physician. The student will demonstrate the ability to: A. Perform a thorough obstetric-gynecologic history as a portion of a general medical history, including: 1. Chief complaint 2. Present illness 3. Menstrual history 4. Obstetric history 5. Gynecologic history 6. Contraceptive history 7. Sexual history 8. Family history 9. Social history B. Interact with the patient to gain her confidence and to develop an appreciation of the effect of her age, racial and cultural background, and economic status on her health; C. Communicate the results of the obstetric-gynecologic and general medical history by well-organized written and oral reports. The OB/GYN Examination Rationale: An accurate examination complements the history, provides additional information and helps determine diagnosis and guide management. It also provides an opportunity to educate and reassure the patient. The student will demonstrate the ability to: A. Interact with the patient to gain her confidence and cooperation, and assure her comfort and modesty B. Perform a painless obstetric-gynecologic examination as part of a woman’s general medical examination, including: 1. Breast examination 2. Abdominal examination 3. Complete pelvic examination 4.
    [Show full text]
  • Female Pelvic Relaxation
    FEMALE PELVIC RELAXATION A Primer for Women with Pelvic Organ Prolapse Written by: ANDREW SIEGEL, M.D. An educational service provided by: BERGEN UROLOGICAL ASSOCIATES N.J. CENTER FOR PROSTATE CANCER & UROLOGY Andrew Siegel, M.D. • Martin Goldstein, M.D. Vincent Lanteri, M.D. • Michael Esposito, M.D. • Mutahar Ahmed, M.D. Gregory Lovallo, M.D. • Thomas Christiano, M.D. 255 Spring Valley Avenue Maywood, N.J. 07607 www.bergenurological.com www.roboticurology.com Table of Contents INTRODUCTION .................................................................1 WHY A UROLOGIST? ..........................................................2 PELVIC ANATOMY ..............................................................4 PROLAPSE URETHRA ....................................................................7 BLADDER .....................................................................7 RECTUM ......................................................................8 PERINEUM ..................................................................9 SMALL INTESTINE .....................................................9 VAGINAL VAULT .......................................................10 UTERUS .....................................................................11 EVALUATION OF PROLAPSE ............................................11 SURGICAL REPAIR OF PELVIC PROLAPSE .....................15 STRESS INCONTINENCE .........................................16 CYSTOCELE ..............................................................18 RECTOCELE/PERINEAL LAXITY .............................19
    [Show full text]
  • Comparison of Curettage and Hysteroscopy Plus Curettage After Uterine Arterial Embolization in the Treatment of Cesarean Scar Pregnancy
    Comparison of Curettage and Hysteroscopy Plus Curettage After Uterine Arterial Embolization in the Treatment of Cesarean Scar Pregnancy Lili Cao Women's Hospital, Zhejiang University School of Medicine Zhida Qian Women's Hospital, Zhejiang University School of Medicine Lili Huang ( [email protected] ) Women's Hospital, Zhejiang University School of Medicine https://orcid.org/0000-0002-5919-3172 Research article Keywords: Cesarean scar pregnancy, Hysteroscopy, Curettage, Uterine artery embolization Posted Date: July 2nd, 2020 DOI: https://doi.org/10.21203/rs.3.rs-39244/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/11 Abstract Background: Caesarean scar pregnancy (CSP) stands for the advanced stage severe complication secondary to cesarean section, and its incidence shows an increasing trend recently. However, no consensus has been reached about the optimal CSP treatment. Methods: The childbearing CSP patients with a cesarean section history were evaluated by ultrasonography, with a gestational age of less than 10 weeks. 34 patients receiving dilation and curettage (D&C) and uterine artery embolization (UAE) were enrolled into the D&C group, while 46 undergoing hysteroscopy (H/S) and D&C after UAE were enrolled into the H/S+D&C group. Results: Differences in success rate and decrease in the β-hCG level in serum on the second day of surgery were not signicant between D&C and H/S+D&C groups (P>0.05). Also, differences in side effect rate, intraoperative blood loss amount, postoperative bleeding time, and total length of stay were not signicant between both groups (P>0.05).
    [Show full text]
  • Pessary Information
    est Ridge obstetrics & gynecology, LLP 3101 West Ridge Road, Rochester, NY 14626 1682 Empire Boulevard, Webster, NY 14580 www.wrog.org Tel. (585) 225‐1580 Fax (585) 225‐2040 Tel. (585) 671‐6790 Fax (585) 671‐1931 USE OF THE PESSARY The pessary is one of the oldest medical devices available. Pessaries remain a useful device for the nonsurgical treatment of a number of gynecologic conditions including pelvic prolapse and stress urinary incontinence. Pelvic Support Defects The pelvic organs including the bladder, uterus, and rectum are held in place by several layers of muscles and strong tissues. Weaknesses in this tissue can lead to pelvic support defects, or prolapse. Multiple vaginal deliveries can weaken the tissues of the pelvic floor. Weakness of the pelvic floor is also more likely in women who have had a hysterectomy or other pelvic surgery, or in women who have conditions that involve repetitive bearing down, such as chronic constipation, chronic coughing or repetitive heavy lifting. Although surgical repair of certain pelvic support defects offers a more permanent solution, some patients may elect to use a pessary as a very reasonable treatment option. Classification of Uterine Prolapse: Uterine prolapse is classified by degree. In first‐degree uterine prolapse, the cervix drops to just above the opening of the vagina. In third‐degree prolapse, or procidentia, the entire uterus is outside of the vaginal opening. Uterine prolapse can be associated with incontinence. Types of Vaginal Prolapse: . Cystocele ‐ refers to the bladder falling down . Rectocele ‐ refers to the rectum falling down . Enterocele ‐ refers to the small intestines falling down .
    [Show full text]
  • Types and Efficacy of Diagnostic Modalities of Ectopic Pregnancy
    Jebmh.com Original Research Article Types and Efficacy of Diagnostic Modalities of Ectopic Pregnancy Pavani Pinjala1 1Department of Obstetrics and Gynaecology Mahavir Institute of Medical Sciences, Vikarabad, Hyderabad, Telangana, India. ABSTRACT BACKGROUND Ectopic pregnancy is not only the gynaecologist’s most critical emergency but also Corresponding Author: one of the major problems because of its difficulties in diagnosis, increased risks Dr. Pavani Pinjala, of mortality, and its profound implications with regard to future reproductive Block – D - 206, Vazhraa Nirmaan Pushpak Apartments, performance. We wanted to study the types and accuracy of various diagnostic Blooming Dale Road, Nizampet, modalities, and effect of various management modalities of ectopic pregnancy. Hyderabad – 500090, Telangana, India. E-mail: [email protected] METHODS This study was conducted at Meenakshi Medical College Hospital and Research DOI: 10.18410/jebmh/2020/568 Institute, Kanchipuram, for a period of 32 months from May 2010 to October 2012. During the same period, there were 2602 reported pregnancies. How to Cite This Article: Pinjala P. Types and efficacy of diagnostic modalities of ectopic RESULTS pregnancy. J Evid Based Med Healthc The incidence of ectopic pregnancy in the study is 15.3 / 1000 reported 2020; 7(47), 2767-2771. DOI: pregnancies. The incidence of ectopic pregnancy in patients with prior abdominal 10.18410/jebmh/2020/568 surgery was 86.6 %. Only 77.5 % patients gave history of typical amenorrhea. Submission 20-08-2020, 22.5 % patients gave history suggestive of atypical amenorrhoea. It was noted Peer Review 28-08-2020, that 55 % cases presented as tubal rupture, 7.5 % as tubal abortion, 35 % cases Acceptance 05-10-2020, presented with intact tubal pregnancy and 2.5 % cases presented as ovarian Published 23-11-2020.
    [Show full text]